MesotheliomaSymptoms, Doctors, Treatments, Advances & More
Mesothelioma Overview
Learn About Mesothelioma
Malignant mesothelioma is an uncommon cancerous tumor. It mainly affects the lining of the lung and chest cavity (pleura) or lining of the abdomen (peritoneum). It is often due to long-term asbestos exposure.
Mesothelioma - malignant; Malignant pleura mesothelioma (MPM)
Long-term exposure to asbestos is the biggest risk factor. Asbestos is a fire-resistant material. It was once commonly found in insulation, ceiling and roofing vinyls, cement, and car brakes. Even though many asbestos workers smoked, experts do not believe smoking itself is a cause of this condition.
Older veterans make up 30% of the cases of mesothelioma due to exposure in the military ship, vehicle, and plane industry.
Men are affected more often than women. The average age at diagnosis is 75 years. Most people seem to develop the condition about 30 years after being in contact with the asbestos.
Symptoms may not appear until 20 to 40 years or longer after exposure to asbestos, and may include:
- Abdominal bloating
- Abdominal pain
- Chest pain, especially when taking a deep breath
- Cough
- Fatigue
- Shortness of breath
- Weight loss
- Fever and sweating
Malignant mesothelioma is a difficult cancer to treat.
There is usually no cure, unless the disease is found very early and the tumor can be completely removed with surgery. Most of the time, when the disease is diagnosed, it is too advanced for surgery. Chemotherapy or radiation may be used to reduce symptoms. Combining certain chemotherapy medicines may help decrease symptoms, but it will not cure the cancer. Immunotherapy is now a common addition to the treatment of mesothelioma.
Participating in a clinical trial (test of new treatments), may give the person more treatment options.
Pain relief, oxygen, and other supportive treatments may also help relieve symptoms.
UT MD Anderson Cancer Center
Anne Tsao is an Oncologist practicing medicine in Houston, Texas. Dr. Tsao is rated as an Elite provider by MediFind in the treatment of Mesothelioma. She is also highly rated in 15 other conditions, according to our data. Her clinical expertise encompasses Mesothelioma, Lung Cancer, Non-Small Cell Lung Cancer (NSCLC), Thymic Epithelial Tumor, and Tissue Biopsy.
Office
Harvey Pass is a Thoracic Surgeon practicing medicine in New York, New York. Dr. Pass is rated as an Elite provider by MediFind in the treatment of Mesothelioma. He is also highly rated in 11 other conditions, according to our data. His clinical expertise encompasses Mesothelioma, Lung Cancer, Lung Nodules, Advanced Bronchoscopy, and Thymectomy.
Penn Radiation Oncology Perelman - 2nd Floor
Keith Cengel is a Radiation Oncologist practicing medicine in Philadelphia, Pennsylvania. Dr. Cengel is rated as an Elite provider by MediFind in the treatment of Mesothelioma. He is also highly rated in 38 other conditions, according to our data. His clinical expertise encompasses Mesothelioma, Lung Cancer, Metastatic Pleural Tumor, Small Cell Lung Cancer (SCLC), and Liver Embolization. Dr. Cengel is board certified in Radiation Oncology, 2008. Dr. Cengel is currently accepting new patients.
You can ease the stress of illness by joining a support group where members share common experiences and problems.
The survival time varies greatly from several months to several years. The outlook depends on:
- The location of the mesothelioma
- The cell type of the mesothelioma
- The stage of the tumor
- The person's age and general health
- Whether surgery is an option
- The person's response to treatment
You and your family may want to start thinking about end-of-life planning, such as:
- Palliative care
- Hospice care
- Advance care directives
- Health care agents
Complications of malignant mesothelioma may include:
- Side effects of chemotherapy or radiation
- Continued spread of cancer to other organs
Make an appointment with your provider if you have symptoms of malignant mesothelioma.
Avoid exposure to asbestos.
Background: * Chromatin is is the structural building block of a chromosome. It is found inside the nucleus of the cell and consists of a complex of DNA and protein. * Cancers of the lung, pleura (lung lining) and esophagus show profound changes in chromatin structure that may affect the course of disease in participants. * A better understanding of these diseases and the genetic changes associated with them ...
Background: A germline mutation is a change to a person s genes that is carried through their DNA. These mutations can be passed on from parents to their offspring. Germline mutations in a gene called BAP1 are linked to the development of mesothelioma and other cancers. Researchers want to follow people with these mutations to learn more.
Published Date: May 01, 2026
Published By: Warren Brenner, MD, Oncologist, Lynn Cancer Institute, Boca Raton, FL. Review provided by VeriMed Healthcare Network. Also reviewed by David C. Dugdale, MD, Medical Director, Brenda Conaway, Editorial Director, and the A.D.A.M. Editorial team.
Davies HE, Sterman D, Lee YCG. Pleural malignancy. In: Broaddus VC, Ernst JD, King TE, et al, eds. Murray and Nadel's Textbook of Respiratory Medicine. 7th ed. Philadelphia, PA: Elsevier; 2022:chap 114.
Kaider-Person O, Zagar T, Haithcock BE, Weiss J. Diseases of the pleura and mediastinum. In: Niederhuber JE, Armitage JO, Kastan MB, Doroshow JH, Tepper JE, eds. Abeloff's Clinical Oncology. 6th ed. Philadelphia, PA: Elsevier; 2020:chap 70.
McCool FD. Diseases of the diaphragm, chest wall, pleura, and mediastinum. In: Goldman L, Cooney KA, eds. Goldman-Cecil Medicine. 27th ed. Philadelphia, PA: Elsevier; 2024:chap 86.
National Cancer Institute website. Malignant mesothelioma treatment (PDQ) -- Health professional version. www.cancer.gov/types/mesothelioma/hp/mesothelioma-treatment-pdq. Updated May 12, 2025. Accessed May 12, 2026.
Rossetti NE, Tohmasi S, Onaitis MW, Kozower BD. Lung, chest wall, pleura, and mediastinum. In: Tyler DS, Hayes-Dixon A, Hines OJ, et al, eds. Sabiston Textbook of Surgery: The Biological Basis of Modern Surgical Practice. 22nd ed. Philadelphia, PA: Elsevier; 2026:chap 110.